Related publications

We collaborate with a number of journals and publish articles related to our reviews and evidence-based medicine in general, with regular ‘Cochrane Corners’ in the journals Paediatric Respiratory Reviews and, more recently, Thorax (see below). We are also working as part of a committee at the Journal of Cystic Fibrosis to produce lay summaries of articles they publish in their journal.


Sarode R, Ballas SK, Garcia A, Kim HC, King K, Sachais B, Williams LA 3rd. Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease. Journal of Clinical Apheresis. 2017 Oct;32(5):342-367. doi: 10.1002/jca.21511. Available here.

Prayle AP, Cox T, Smith SJ, Rycroft-Malone J, Thomas KS, Hughes DA, Smyth AR. Do guidelines for treating chest disease in children use Cochrane Reviews effectively? A systematic review. Thorax 2017. (epub ahead of print) DOI 10.1136/thoraxjnl-2016-208790. Available here.

Rowbotham NJ, Smyth AR. The patient voice in research - Supporting actor or starring role? Journal of Cystic Fibrosis 2017; 16(3): 313-4. Available here.

Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott ZC, et al. The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers. Thorax 2017 Aug 4. pii: thoraxjnl-2017-210473. doi: 10.1136/thoraxjnl-2017-210473. [Epub ahead of print]. Available here.


Smyth A. Treatment of pulmonary exacerbations in cystic fibrosis – could do better? Paediatric Respiratory Reviews. 2016; 20, Supplement: 6-7. Available here.

Palser SC, Rayner OC, Leighton PA, Smyth AR. Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study. BMJ Open 2016; 6(12):e012303. Available here.


Singh PC, Ballas SK. Emerging drugs for sickle cell anemia. Expert Opinion on Emerging Drugs. 2015;20(1):47-61. Available here.

Wilson LM, Robinson KA. Understanding and interpreting guideline recommendations made with insufficient evidence. Paediatric Respiratory Reviews. 2015; 16(1): 49–50. Available here.

Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review). Paediatric Respiratory Reviews. 2015; 16(2): 108–9. Available here.

Waters V, Smyth A. Cystic fibrosis microbiology: Advances in antimicrobial therapy. Journal of Cystic Fibrosis 2015; 14(5):551-60. Available here.


Smyth AR. Evidence into practice: How do we get past the roadblocks? Paediatric Respiratory Reviews. 2014; 15(1):45-6. Available here.

Smyth AR, Campbell EL. Prescribing practices for intravenous aminoglycosides in UK Cystic Fibrosis clinics: A questionnaire survey. Journal of Cystic Fibrosis 2014;13(4):424-27. Available here.

Castellani C, Conway S, Smyth AR, Stern M, Stuart Elborn J. Standards of Care for Cystic Fibrosis ten years later. Journal of Cystic Fibrosis 2014; 13 (Supp 1): S1-S2. Available here.

Smyth AR, Bell SC, Bojcin S, et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. Journal of Cystic Fibrosis 2014;13 (Suppl 1):S23-S42. Available here.

Cox NS, Alison JA, Holland AE. Interventions to promote physical activity in people with cystic fibrosis. Paediatric Respiratory Reviews. 2014; 15(3):237-9. Available here.

Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033-48. Available here.

Ballas SK. Sickle Cell Pain, Second Edition. Washington DC: International Association for the Study of Pain; 2014. 

van Zuuren EJ, Fedorowicz Z. Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review. Hemoglobin 2014: 38(3):221-3. Available here.

Bradley J, O’Neill K, Dentice R, Elkins MR. Improving airway clearance in cystic fibrosis. European Respiratory Monograph, 2014; 64: 169-87. Available here.


Ryan G, Jahnke N, Remmington T, Smyth A. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Paediatric Respiratory Reviews. 2013; 14 (1); 27–8. Available here.

Daniels T, Mills N, Whitaker P. Nebuliser systems for drug delivery in cystic fibrosis. Paediatric Respiratory Reviews. 2013; 14 (2): 98–9. Available here.

Welsh E, Jahnke N, Remmington T, Smyth A, Cates C. 20 Years of Cochrane Glancing backwards – Moving ahead: a tale of two Cochrane Review Groups. Paediatric Respiratory Reviews. 2013; 14 (3): 165–7. Available here.

Thaker V, Carter B. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Paediatric Respiratory Reviews. 2013; 14 (4): 232–3. Available here.


Hurley MN, Prayle AP. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis. Paediatric Respiratory Reviews. 2012;13(3):160-1. Available here.

Southern KW. Macrolide antibiotics for cystic fibrosis. Paediatric Respiratory Reviews. 2012; 13 (4): 228–9. Available here.